This symposium will present state-of-the-art of the translational research in ophthalmology.
The first part will be dedicated to genetic of inherited retinal dystrophies and the importance to maintain a patient register. Speakers will next describe diff erent cellular pathways involved in retinal degenerations such as AMD, dystrophies, and uveitis, as well as epigenetic alterations in retinal dystrophies and uveal melanoma.
The development of new technologies to better access the retina and to visualize in vivo the retina with a cellular resolution will be presented. Finally, the program ends with a session dedicated to new therapies with an emphasis on drug, gene and cell delivery.
- 09:00-10:05 How to deal with gene defect ?
- 10:30-12:05 Disease mechanisms I
- 13:20-14:25 Disease mechanisms II
- 14:25-15h15 New technologies
- 15:45-17:40 Drug, gene and cell therapies
Prof. Thomas J. Wolfensberger
Prof. Reinier Schlingemann
Prof. Yvan Arsenijevic
Dre Irmela Mantel
Dr Alexandre Moulin
Dr Olivier Lorentz
October 11th, from 08.15 to 18.00